Treatment for sickle cell disease, the most common inherited blood disorder in Kenya, has been approved for use in England for older children and adults with a severe form of the disease.The treatment ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

(B) After the Valsalva maneuver, a large volume of microbubbles is filling the left ventricular and subsequently the left ventricular. Although intradiscal oxygen–ozone therapy is a low-risk procedure ...

Advt Sickle cell disease is a serious and lifelong condition caused by errors in the genes for haemoglobin, which is used by red blood cells to carry oxygen around the body. The therapy involves ...

Transfusions of red blood cells (RBCs) can be life-saving treatments for patients suffering from anemia, where the body lacks enough healthy RBCs to effectively deliver oxygen around the body. But the ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

[7] It is not known whether a chronically low Hb confers any compensating mechanisms that may affect oxygen delivery to vital organs and improve survival during acute blood loss. In other words ...

The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...